Alzheimer's Treatment Options in Cuba for New York Families

Cuba offers a comprehensive range of Alzheimer's treatment options, each addressing different aspects of the disease. Understanding these options helps American families make informed decisions in consultation with their U.S. neurologist.

The treatment options available in Cuba include: NeuroEPO neuroprotective research (recombinant erythropoietin for intranasal delivery, investigated for neuroprotective effects in mild-to-moderate Alzheimer's — not FDA-approved, not available in the U.S.); intensive cognitive rehabilitation at CIREN (4–6 hours of daily multidisciplinary therapy for 4–8 weeks — 20–30× more therapy than U.S. standard care); pharmacological management (optimization of cholinesterase inhibitors, memantine, and other medications by a Cuban neurologist); comprehensive clinical evaluation (neuropsychological testing, MRI review, blood work, multidisciplinary team assessment); and mandatory caregiver education (hands-on training in cognitive stimulation, daily care, communication, behavioral management, and self-care).

These options are not mutually exclusive — most patients receive a combination of treatments tailored to their individual needs. No treatment cures Alzheimer's. The goal is to slow cognitive decline, maintain function and independence, manage behavioral symptoms, and improve quality of life. Treatment suitability is determined only after individual medical evaluation.